Anavex Life Sciences Corp (AVXL)

Anavex Life Sciences Corp (AVXL) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $121M; returns 1 day -2.2%, 1 week +1.5%, 1 year -84.8%.

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company dedicated to developing innovative small molecule therapeutics for neurodegenerative, neurodevelopmental, and neuropsychiatric disorders.

Groups AVXL belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Pharmaceuticals
• Neuroscience
• CNS Disorders
• Neurological Disorders
• Alzheimer's Disease
• Rett Syndrome
• Healthcare
• Clinical Stage
• Rare Diseases
• Life Sciences
• R&D

AVXL financial model: income statement, cash flow and balance sheet